Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Honey eyedrops: a sweet solution for dry eyes?

NCT ID NCT07279324

Symptom relief Sponsor: Universiti Sains Malaysia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether eyedrops made from Kelulut honey (from stingless bees) are safe and can ease dry eye symptoms. 45 adults will use one of three strengths of honey drops three times a day for a month, while continuing their usual treatments. Researchers will check tear stability and eye comfort at follow-up visits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 45 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18-50 years at the time of consent. 2. Clinical diagnosis of dry eye disease in at least one eye, based on symptoms and clinical signs (Symptomatic dry eye, defined as an OSDI score ≥ 13; objective evidence of tear film instability, such as TBUT \< 10 seconds in at least one eye) 3. Participants may be Treatment-naïve, OR on stable dry eye treatment for at least 2 weeks before enrollment. 4. Willing to use Kelulut honey eyedrops three times daily for 1 month as instructed. 5. Able and willing to attend all study visits (Baseline, Week 2, Week 4). Exclusion Criteria: 1. Known allergy or hypersensitivity to honey, bee products, or any component of the study formulations. 2. Active ocular infection or inflammation (e.g., infectious conjunctivitis, keratitis, uveitis). 3. Severe allergic conjunctivitis or other ocular surface diseases 4. Significant meibomian gland dysfunction or blepharitis 5. Ocular surgery or laser procedures within the past 6 months. 6. Use of topical ocular medications other than lubricants within the past 30 days 7. Contact lens wear within 1 week prior to baseline or expected during the study. 8. Punctal plugs or other lacrimal procedures within the last 3 months. 9. Systemic diseases that significantly affect the ocular surface and are unstable or uncontrolled (e.g., uncontrolled Sjögren's, uncontrolled rheumatoid arthritis, uncontrolled diabetes). 10. Participation in another clinical trial or receipt of an investigational product within the past 30 days. 11. Pregnant or breastfeeding women, or those planning pregnancy during the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dry eye disease (DED) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dry eye syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dry eye disease (DED) Dry eye symptoms Dry eye syndrome (DES)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital Pakar Universiti Sains Malaysia

    Kota Bharu, Kelantan, 16150, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.